{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-007195","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2024-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.813099+00:00","generated_at":"2026-06-05T12:45:54.470315+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Agilon health Q4 net loss $230M, medical margin negative $102M; FY2024 guidance slashed","bullets":["Q4 revenue $1.06B (+72% YoY) but gross profit of negative $95M vs $16M a year ago.","Full-year 2023 net loss $263M vs $107M in 2022; Adjusted EBITDA loss $95M.","Medical margin for Q4 negative $102M; FY2023 $299M vs guidance midpoint $350M.","FY2024 medical margin guidance cut to $400-450M from prior $560-600M; Adj. EBITDA now loss of $60-15M vs prior profit $40-60M.","Class of 2025 adds at least 60K MA members across 5 physician groups; entry costs lowered to $55-65M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-007195","json":"https://secwatch.observer/filing/0001628280-24-007195.json","markdown":"https://secwatch.observer/filing/0001628280-24-007195.md","text":"https://secwatch.observer/filing/0001628280-24-007195.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024007195/0001628280-24-007195-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024007195/agl-20240227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T12:45:54.470315+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f9b65ec73a888dfe9140fb4a6e6a482d516c8560","claim":"agilon health, inc. reported the three and twelve months ended December 31, 2023 results: revenue Total revenue of $1.06 billion in the fourth quarter 2023 increased 72% compared to $615 million in the fourth quarter 2, net income Net loss of $230 million in the fourth quarter 2023 compared to a loss of $57 million in the fourth quarter 2022. For th. Guidance reaffirmed.","evidence_excerpt":"On February 27, 2024 , agilon health, inc. (“agilon” or the “Company”), a Delaware corporation, issued a press release setting forth its financial results for the three and twelve months ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024007195/0001628280-24-007195-index.htm","confidence":0.96,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and twelve months ended December 31, 2023"},{"label":"Revenue","value":"Total revenue of $1.06 billion in the fourth quarter 2023 increased 72% compared to $615 million in the fourth quarter 2"},{"label":"Net income","value":"Net loss of $230 million in the fourth quarter 2023 compared to a loss of $57 million in the fourth quarter 2022. For th"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}